Bicoll
Private Company
Funding information not available
Overview
Bicoll is a privately held, revenue-generating service and platform company with a 20-year track record in natural product chemistry. It operates at the intersection of plant-based compound discovery and medicinal chemistry, offering proprietary libraries (e.g., BILOBAC N™) and separation technologies (e.g., BIFRAC N™) to industry and academic partners. The company is strategically focused on high-value areas like neurodegeneration and longevity, building a pipeline of preclinical candidates while also engaging in collaborative R&D projects for taste modulation and metabolic health.
Technology Platform
Integrated platform combining proprietary plant-based compound libraries (BILOBAC N™), advanced separation technology (BIFRAC N™), physicochemical preselection (BIPRESELECT™), and AI/data-mining for natural product discovery and optimization.
Opportunities
Risk Factors
Competitive Landscape
Bicoll competes with other natural product discovery firms (e.g., Phytopharm, Naprogenix) and a broad array of biotech companies using AI/ML for small-molecule discovery. Its unique differentiator is its deep, two-decade specialization in plant-based chemistry integrated with modern medicinal chemistry and prescreening techniques.